Veerhealth Care Stock Screener | Share Price & Fundamental Analysis
VEERHEALTH
Pharmaceuticals
Screen Veerhealth Care share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price BSE
₹18.98
▲
0.23 (1.23%)
Market Cap
₹35.72 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
1.57
EPS (TTM)
₹0.20
Dividend Yield
-
Debt to Equity
0.11
52W High
₹23.05
52W Low
₹10.07
Operating Margin
4.00%
Profit Margin
5.26%
Revenue (TTM)
₹19.00
EBITDA
₹2.00
Net Income
₹1.00
Total Assets
₹34.00
Total Equity
₹22.00
Veerhealth Care Share Price History - Stock Screener Chart
Screen VEERHEALTH historical share price movements with interactive charts. Analyze price trends and patterns.
Veerhealth Care Company Profile - Fundamental Screener
Screen Veerhealth Care company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for VEERHEALTH shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE882C01035
Veerhealth Care Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen VEERHEALTH balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 34 | 28 | 25 | 20 | 19 | 18 | 16 | 15 | 13 | 14 |
| Current Assets | 11 | 14 | 10 | 6 | 7 | 6 | 3 | 7 | 8 | 7 |
| Fixed Assets | 20 | 12 | 12 | 11 | 10 | 10 | 6 | 6 | 3 | 3 |
| Liabilities | ||||||||||
| Total Liabilities | 34 | 28 | 25 | 20 | 19 | 18 | 16 | 15 | 13 | 14 |
| Current Liabilities | 8 | 4 | 3 | 4 | 3 | 3 | 0 | 0 | 1 | 1 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 22 | 22 | 21 | 14 | 14 | 14 | 13 | 13 | 13 | 13 |
| Share Capital | 20 | 20 | 10 | 7 | 7 | 7 | 7 | 7 | 7 | 7 |
| Reserves & Surplus | 2 | 2 | 11 | 7 | 7 | 7 | 6 | 6 | 6 | 6 |
Screen VEERHEALTH income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 19 | 18 | 15 | 15 | 11 | 12 | 12 | 6 | 6 | 3 | 3 | 2 |
| Expenses | 18 | 16 | 13 | 13 | 10 | 11 | 11 | 6 | 5 | 2 | 2 | 2 |
| EBITDA | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 |
| Operating Profit % | 4.00% | 3.00% | 5.00% | 4.00% | -9.00% | 1.00% | 6.00% | 7.00% | -2.00% | -19.00% | -1.00% | -12.00% |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| Tax | 0 | 0 | 1 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 1 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS | 0.20 | 0.20 | 0.21 | 1.52 | -0.11 | 0.55 | 0.46 | 0.23 | 0.20 | 0.03 | 0.00 | 0.01 |
Veerhealth Care Cash Flow Screener - Liquidity Fundamentals
Screen VEERHEALTH cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 0 | 3 | -1 | 2 | 1 | 0 | 2 | 2 | 2 | 0 |
| Investing Activities | -8 | 0 | -2 | -1 | 0 | -2 | -2 | -3 | 0 | 0 |
| Financing Activities | 10 | -6 | 6 | 0 | -1 | 2 | 0 | 1 | -1 | 0 |
| Net Cash Flow | 1 | -3 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Screen VEERHEALTH shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 31.50% | 31.50% | 31.50% | 30.41% | 30.41% | 30.41% | 30.41% | 30.76% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 58.35% | 57.92% | 56.97% | 60.05% | 59.25% | 58.57% | 58.53% | 55.14% |
| Other Holding | 10.15% | 10.58% | 11.53% | 9.54% | 10.33% | 11.02% | 11.06% | 14.10% |
| Shareholder Count | 11,390 | 11,011 | 10,846 | 10,991 | 10,255 | 11,489 | 11,469 | 3,605 |
Veerhealth Care Dividend Screener - Share Yield Analysis
Screen VEERHEALTH dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
Veerhealth Care Index Membership - Market Screener Classification
Screen VEERHEALTH by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Veerhealth Care Market Events Screener - Corporate Actions
Screen VEERHEALTH market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | -17.87% | ||
| Annual General Meeting | NA | -1.25% | ||
| Bonus | 1:1 | 1.28% | ||
| 2025-11-12 | 2025-11-12 | Quarterly Result Announcement | NA | -2.31% |
| 2025-08-12 | 2025-08-12 | Quarterly Result Announcement | NA | -0.86% |
| 2025-05-30 | 2025-05-30 | Quarterly Result Announcement | NA | 15.31% |
| 2025-02-12 | 2025-02-12 | Quarterly Result Announcement | NA | -7.02% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -8.66% |
Veerhealth Care Competitors Screener - Peer Comparison
Screen VEERHEALTH competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 424,634 | 39.93 | 54,729 | 9.71% | 10,980 | 49.55 |
| Divis Laboratories | 172,860 | 69.20 | 9,712 | 18.67% | 2,191 | 56.33 |
| Torrent Pharmaceuticals | 129,151 | 60.10 | 11,539 | 6.99% | 1,911 | 61.47 |
| Cipla | 122,205 | 22.55 | 28,410 | 7.12% | 5,291 | 49.47 |
| Dr Reddys Laboratories | 107,114 | 18.60 | 33,741 | 16.73% | 5,725 | 60.05 |
| Lupin | 97,120 | 22.34 | 22,910 | 13.74% | 3,306 | 65.28 |
| Zydus Life Science | 92,392 | 18.40 | 23,511 | 18.55% | 4,615 | 40.07 |
| Mankind Pharma | 90,241 | 50.59 | 12,744 | 20.90% | 2,007 | 45.53 |
| Aurobindo Pharma | 71,119 | 20.79 | 32,346 | 9.43% | 3,484 | 59.88 |
| Alkem Laboratories | 67,243 | 27.59 | 13,458 | 3.70% | 2,216 | 49.80 |
Veerhealth Care Company Announcements - News Screener
Screen VEERHEALTH latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2025-12-08 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-12-08 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-11-27 | Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order | View |
| 2025-11-20 | Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order | View |
| 2025-11-12 | Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer | View |
| 2025-11-12 | Results-Financial Results For September 30 2025 | View |
| 2025-11-12 | Board Meeting Outcome for Outcome Of Board Meeting | View |
| 2025-11-05 | Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results Of The Company For The Quarter And Half Year Ended 30Th September 2025. | View |
| 2025-11-01 | Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order | View |
| 2025-10-28 | Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order | View |
| 2025-10-18 | Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order | View |
| 2025-10-07 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-10-01 | Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order | View |
| 2025-10-01 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |
| 2025-09-30 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-09-26 | Closure of Trading Window | View |
| 2025-09-17 | Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order | View |
| 2025-09-05 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-08-22 | Reg. 34 (1) Annual Report. | View |
| 2025-08-22 | Shareholder Meeting - AGM On September 30 2025 | View |